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Abstract
Background: A recent article by Reeves et al. on the identification and resolution of ambiguities
in the 1994 chronic fatigue syndrome (CFS) research case definition recommended the Checklist
Individual Strength, the Chalder Fatigue Scale, and the Krupp Fatigue Severity Scale for evaluating
fatigue in CFS studies. To be able to discriminate between various levels of severe fatigue, extreme
scoring on the individual items of these questionnaires must not occur too often.
Methods: We derived an expression that allows us to compute a lower bound for the number of
items with the maximum item score for a given study from the reported mean scale score, the
number of reported subjects, and the properties of the fatigue rating scale. Several CFS studies that
used the recommended fatigue rating scales were selected from literature and analyzed to verify
whether abundant extreme scoring had occurred.
Results: Extreme scoring occurred on a large number of the items for all three recommended
fatigue rating scales across several studies. The percentage of items with the maximum score
exceeded 40% in several cases. The amount of extreme scoring for a certain scale varied from one
study to another, which suggests heterogeneity in the selected subjects across studies.
Conclusion: Because all three instruments easily reach the extreme ends of their scales on a large
number of the individual items, they do not accurately represent the severe fatigue that is
characteristic for CFS. This should lead to serious questions about the validity and suitability of the
Checklist Individual Strength, the Chalder Fatigue Scale, and the Krupp Fatigue Severity Scale for
evaluating fatigue in CFS research.
Text
Since ambiguities in the 1994 chronic fatigue syndrome
(CFS) research case definition [1] do indeed contribute to
inconsistenties in the identification of cases, I welcome
the publication by Reeves et al. [2] and the authors' efforts
to resolve these problems. However, I have to express my
deepest concerns about the three instruments that the
authors have recommend for measuring fatigue in
research studies on CFS. Because all three instruments eas-
ily reach the extreme ends of their scales on a large
number of the individual items, they do not accurately
represent the severe fatigue that is required to satisfy any
of the published CFS research case definitions [1,3-5].
This low ceiling effect seriously distorts the fatigue meas-
urements, which will inevitably result in bias and poten-
tially misleading results.
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To verify that the three recommended instruments do
indeed exhibit low ceiling effects, one can study the mean
scale scores that are reported in the literature. The recom-
mended instruments were the Checklist Individual
Strength (CIS) [6], the Chalder Fatigue Scale [7], and the
Krupp Fatigue Severity Scale [8]. Each of these question-
naires consists of a fixed number of questions or state-
ments. The answer to each question or the degree to which
the participant agrees with a statement is scored on a cer-
tain scale. A question or statement with its corresponding
scale is referred to as an item, and the assigned value cor-
responding to the participant's answer as the item score. A
participant's fatigue rating scale score Y is computed by
summing his individual item scores.
We can derive a lower bound L for the number of items
with a maximum score for a given study by combining the
reported mean fatigue rating scale score with the proper-
ties of the scale. Let us denote the reported number of sub-
jects by n and the mean scale score of these subjects by  .
We consider instruments that consist of N items, with m
possible scores for each item. Each item score is an ele-
ment of the set {S1, S2,..., Sm - 1, Sm}, where Si - 1 <Si. Hence,
S1 and Sm are respectively the minimum and maximum
possible item scores. We count the number of items with
a certain score Si, and denote this number by ki. Because
we have n individuals who each answered N questions,
the ki's add up to nN. Consequently,
The sum of the item scores of all individuals together is
equal to n . Moreover, it is also equal to  .
Since Si - 1 <Si, we find that
Hence, we find that the lower bound L that we were look-
ing for is given by
If L should be negative, which happens when   is less
than N Sm - 1, then we set L to zero. A lower bound for the
percentage of items with the maximum score is
. Note that this percentage is independent of
the number of subjects in the study.
Lower bounds L for the number of items with the maxi-
mum score corresponding to data reported in literature
were computed for each of the recommended fatigue rat-
ing scales. Because a recent Dutch article [9] recom-
mended the Shortened Fatigue Questionnaire (SFQ) for
assessing fatigue in clinical practice, this scale was also
included in the analysis. The SFQ is simply a reduced ver-
sion of the CIS 'fatigue severity' subscale, so the two are
closely related.
At least two articles per fatigue rating scale were selected
on a rather arbitrary basis. Subjects fulfilled the CDC88-
CFS [3], Oxford-CFS [5], CDC94-CFS [1], or CDC94-UCF
(unexplained chronic fatigue, i.e. either CFS or idiopathic
chronic fatigue) [1] criteria. In particular, the study by Ver-
coulen et al. [10] was selected because it contains detailed
data on the distribution of the scores for each CIS sub-
scale. The study by Alberts et al. [11] was included because
it contained normative data for the SFQ. The study by Ver-
meulen et al. [12] was selected to also include data on the
SFQ from another source than the University Medical
Centre Nijmegen. The article by Jason et al. [13] was
selected because it was specifically concerned with the
reliability and validity of a screening instrument for CFS.
A recent Cochrane review [14] has investigated the relative
effectiveness of exercise therapy and control treatments
for CFS. All four studies that were included in that review
and that have already been published [15-18] were ana-
lyzed here (one study by Moss-Morris et al. that was
included in the review was submitted but not yet pub-
lished). The other studies were selected because they were
easily available to the author. Baseline data for Friedberg
and Krupp [19] and Deale et al. [20] were read from the
graphs presented in the articles. It is remarked that the
'matched ambulant group' in Van der Werf et al. [21] is a
subset of the 'total ambulant group' in that study. Further-
more, the 'research participants' in Van der Werf et al. [22]
are the same subjects as the 'total ambulant group' in [21].
The lower bounds for the number of items with the max-
imum score are presented in Table 1. From the lower
bounds listed in the last column of the table we see that
for several studies the number of items with the maxi-
mum score is larger than 40%. It is emphasized that the
lower bounds were derived assuming a worse case sce-
nario for the distribution of the item scores, i.e. partici-
pants have either the highest or the second highest
possible score on each item. Since the worse case distribu-
tion is quite unrealistic, in reality the percentages of items
with the maximum score are generally (even) higher than
the values reported in the table. For example, according to
the table it is not possible to conclude that extreme scor-
ing occurred on the 'physical activity' subscale of the CIS
in the study by Vercoulen et al. [10]. However, according
to additional data listed in that article the 80th percentile
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Table 1: Lower bounds for the number of items with the maximum score for several studies. N is the number of items that constitute 
the (sub)scale, Sm is the maximum possible individual item score, n is the reported number of subjects,   is the reported mean 
(sub)scale score, and L is the derived lower bound for the number of items with the maximum score. The last column lists a lower 
bound for the percentage of items with the maximum score based on L. The second highest possible item score Sm - 1 m is equal to Sm - 
1 for all considered (sub)scales.
Scale NS m nL
Checklist Individual Strength Oxford-CFS, CDC94-UCF; Vercoulen et al. [10]
-fatigue severity subscale 8 7 758 51.7 2805 46%
-physical activity subscale 3 7 758 16.9 0 0%
-reduced motivation subscale 4 7 758 17.0 0 0%
-concentration subscale 5 7 758 27.5 0 0%
Checklist Individual Strength CDC94-UCF; van der Werf et al. [21]
-homebound group; fatigue severity subscale 8 7 18 53.6 101 70%
-matched ambulant group; fatigue severity subscale 8 7 32 52.8 154 60%
-total ambulant group; fatigue severity subscale 8 7 270 52.1 1107 51%
-homebound group; physical activity subscale 3 7 18 15.8 0 0%
-matched ambulant group; physical activity subscale 3 7 32 17.0 0 0%
-total ambulant group; physical activity subscale 3 7 270 17.6 0 0%
-homebound group; concentration subscale 5 7 15 22.4 0 0%
Shortened Fatigue Questionnaire van der Werf et al. [22]
-survey respondents (Dutch ME-Association members) 4 7 1955 23.9 0 0%
-research participants (CDC94-UCF) 4 7 270 26.1 567 53%
Shortened Fatigue Questionnaire Oxford-CFS, CDC94-UCF; Alberts et al. [11]
-normative data for CFS 4 7 445 26 to 27 890 50%
Shortened Fatigue Questionnaire CDC94-CFS; Vermeulen et al. [12]
- s t u d y  g r o u p 4 73 5 2 4 . 82 820%
Krupp Fatigue Severity Scale CDC88-CFS; Friedberg et al. [19]
-treatment group 9 7 22 58 88 44%
-no-treatment group 9 7 22 51 0 0%
Krupp Fatigue Severity Scale CDC88-CFS; DeLuca et al. [23]
-subjects with concurrent axis 1 psychiatric disorder 9 7 12 58.5 54 50%
-subjects without concurrent psychiatric disorder 9 7 21 57.2 67 36%
14-item Chalder Fatigue Scale Oxford-CFS; Wearden et al. [15]
-'exercise and fluoxetine group' 14 3 33 35.9 261 56%
-'exercise and placebo group' 14 3 34 33.7 194 41%
-'exercise control and fluoxetine group' 14 3 35 34.4 224 46%
-'exercise control and placebo group' 14 3 34 34.0 204 43%
14-item Chalder Fatigue Scale Oxford-CFS; Fulcher et al. [16]
-exercise group 14 3 33 28.9 30 6%
-fiexibility group 14 3 33 30.5 83 18%
Y
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of the 'physical activity' subscale is equal to the maximum
possible subscale score of 3 × 7 = 21. Thus approximately
20% of the subjects reached the extreme score on all of
their items, from which we can infer that extreme scoring
occurred on at least 20% of the items.
It should be clear that extreme scoring on a large number
of items occurred for all scales across several studies. Only
the 'concentration' and 'reduced motivation' subscales of
the CIS did not show evidence of extreme scoring. That
the amount of extreme scoring for a certain scale varies
from one study to another suggests heterogeneity in the
selected subjects across studies. Since the studies that were
analyzed were selected on a rather arbitrary basis and not
in a systematic way, the data in Table 1 should not be
regarded as a true reflection of the CFS literature as a
whole. The main point is that it does prove that abundant
extreme scoring occurred for all the recommended fatigue
rating scales in at least some of the CFS studies published
in literature.
One only needs to glance at the three recommended
instruments to understand why extreme scoring occurs so
often. The CIS and the Krupp Fatigue Severity Scale consist
of statements like "I feel tired" and "I am easily fatigued"
that are scored on seven-point scales (from "yes, that is
true" to "no, that is not true" for the CIS; from "strongly
disagree" to "strongly agree" for the Krupp scale). Thus it
does not matter whether a subject feels 'extremely tired,'
'severely tired' or 'just tired,' and is 'easily extremely
fatigued,' 'easily severely fatigued' or 'easily fatigued;' he
will score on the extreme end of the scale for all these
cases. A similar argument applies to the Chalder Fatigue
Scale, where the participant has to choose from one of
four answers like "less than usual," "no more than usual,"
"more than usual" and "much more than usual" to ques-
tions such as "Do you feel weak?" For the continuous ver-
sion of the Chalder scale answers are rated from 0 to 3, for
the bimodal version the scoring system is {0, 0, 1, 1}. This
explains why the binary version performs even worse than
the continuous version.
11-item Chalder Fatigue Scale CDC94-CFS; Jason et al. [13]
-physical subscale 7 3 15 18.40 66 63%
-mental subscale 4 3 15 9.13 17 28%
11-item Chalder Fatigue Scale CDC94-CFS; Wallman et al. [17]
-exercise group; physical subscale 7 3 32 11.6 0 0%
-exercise group; mental subscale 4 3 32 6.3 0 0%
-relaxation/flexibility group; physical subscale 7 3 29 11.4 0 0%
-relaxation/flexibility group; mental subscale 4 3 29 5.6 0 0%
11-item bimodal Chalder Fatigue Scale Oxford-CFS and CDC94-CFS; Deale et al. [20]
-cognitive behavior therapy group 11 1 30 10.1 303 92%
-relaxation group 11 1 30 9.3 279 85%
11-item bimodal Chalder Fatigue Scale Oxford-CFS; Powell et al. [18]
-control group 11 1 34 10.6 360 96%
-minimum intervention group 11 1 37 10.4 385 95%
-telephone intervention group 11 1 39 9.9 386 90%
-maximum intervention group 11 1 38 10.2 388 93%
Table 1: Lower bounds for the number of items with the maximum score for several studies. N is the number of items that constitute 
the (sub)scale, Sm is the maximum possible individual item score, n is the reported number of subjects,   is the reported mean 
(sub)scale score, and L is the derived lower bound for the number of items with the maximum score. The last column lists a lower 
bound for the percentage of items with the maximum score based on L. The second highest possible item score Sm - 1 m is equal to Sm - 
1 for all considered (sub)scales. (Continued)
YBMC Health Services Research 2005, 5:37 http://www.biomedcentral.com/1472-6963/5/37
Page 5 of 6
(page number not for citation purposes)
Interestingly, the ceiling effect has been noted before by
members of the International CFS Study Group in their
individual publications: "The CIS-fatigue score [i.e. the
'fatigue severity' subscale of the CIS] involves an overall
rating and in CFS samples easily reaches the extreme end
of its scale" [21]; "a ceiling effect in the [Krupp] Fatigue
Severity Scale may limit its utility to assess severe fatigue-
related disability" [24]. A publication that examined the
distribution of the 14 items of the Chalder Fatigue Scale
in 136 CFS patients found that "Scores on eight items
were normally distributed, but six items ('tiredness,' 'rest-
ing more,' 'lacking energy,' 'feeling weak,' 'feeling sleepy
or drowsy,' and 'starts things without difficulty but gets
weaker as goes on') were highly skewed with the majority
of patients reaching the maximum score" [25].
Abundant extreme scoring and the corresponding inabil-
ity to discriminate between various levels of severe fatigue
can lead to misleading results in several ways. For exam-
ple, van der Werf et al. [21] compared a group of 18 home-
bound CF(S) patients with a group of 32 matched
ambulant CF(S) patients. No significant difference was
found when fatigue was measured with the CIS 'fatigue
severity' subscale (p = 0.39). But when fatigue was meas-
ured with the 'Daily Observed Fatigue' scale that does not
exhibit such a strong ceiling effect, it was concluded that
the homebound group was significantly more fatigued
than the ambulant group (p < 0.01). Another problem
occurs when studying the relation between the experi-
enced level of fatigue and another factor such as social
support. Then the correlation between the two will cer-
tainly be distorted if the fatigue measurement has a low
ceiling effect and the other measure has not. The most
dangerous situation however arises when a scale with low
ceiling is used as a primary outcome measure to evaluate
a CFS treatment. Consider five patients with a baseline
CIS-fatigue score of 52 (e.g. the mean baseline score in
Prins et al. [26] was 52.1). Suppose one patient improves
(e.g. CIS-fatigue = 16 at follow-up) and the other four
patients become extremely fatigued due to treatment
(CIS-fatigue = 56 at follow-up, i.e. the maximum scale
score). Then still the overall mean has improved from 52
to 48, even though 80% of the subjects are substantially
more fatigued after treatment. In particular, participants
who already have the maximum scale score at baseline
can never get worse according to the 'recommended'
fatigue rating scales. Systematic errors that may result in
artificial treatment effects opposite to the true situation
should be avoided at all times.
Unfortunately, the reasons for recommending the CIS, the
Krupp and the Chalder scales in the main article text are
limited to 'they have been used before,' 'normative data
have been collected' and 'receiver-operating characteristics
have been published.' In the Author's response to reviews
(25 July 2003) that is available on the pre-publication site
of the article, the authors remark that these are all 'stand-
ardized, validated, internationally accepted instruments'
without giving any reference to support this statement.
Although the recommended fatigue rating scales might
indeed be accepted by numerous scientists of various
nationalities, the evidence presented here must lead to
serious questions about their validity and suitability for
CFS research.
Noticeably, the Profile of Fatigue-Related Symptoms
(PFRS) that was developed more than a decade ago by Ray
et al. [27,28] is a rating scale that does not has the flaw of
low ceiling in CFS samples. It consists of the four sub-
scales 'Emotional Distress,' 'Cognitive Difficulty,' 'Fatigue'
and 'Somatic Symptoms.' All subscales have high reliabil-
ity and showed good convergence with comparison meas-
ures. Why was the PFRS not included in the authors'
advice? To shed some light on the underlying scientific
process that has ultimately led to their recommendations,
I would like to ask the authors to make the workshop
summaries and the focus group reports available.
Strictly speaking, the CIS, the Krupp Fatigue Severity Scale
and the Chalder Fatigue Scale are all able to discriminate
between CFS subjects and healthy subjects. Thus all three
might indeed be used to improve the precision of CFS case
ascertainment for research studies. However, if one really
wishes to take CFS research forwards instead of three steps
backwards, then it would be wise to abandon these low
ceiling fatigue rating scales and start focussing on instru-
ments that accurately represent the severe fatigue that is
currently defined to be so characteristic for CFS.
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